SCHEMBL16148754

SCHEMBL16148754

COC(=O)c1ccc(Nc2cc(C(C)(C)C)ccc2O)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 2/20 0.50
▸ PDK2 Q15119 2/20 0.50
▸ PDK3 Q15120 2/20 0.50
▸ PDK4 Q16654 2/20 0.50
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ LMNA P02545 3/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ NPY1R P25929 1/20 0.47
▸ NPY2R P49146 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ BCL6 P41182 1/20 0.47
▸ BCOR Q6W2J9 1/20 0.47
▸ CA12 O43570 1/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ CA7 P43166 1/20 0.47
▸ XDH P47989 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16148312 0.89 PDK1 (0.52) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL16148870 0.88 MDH1 (0.47) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL16147786 0.86 CA1 (0.48) SMN1; SMN2ALDH1A1LMNAKDM4EMAPT
SCHEMBL16148498 0.83 BCL6 (0.50) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL16148223 0.83 NOTUM (0.47) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL16148950 0.82 ACLY (0.49) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL16147742 0.82 ALDH1A1 (0.56) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL16147540 0.81 CA12 (0.43) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL16148132 0.79 EGFR (0.55) SMN1; SMN2LMNAKDM4EMAPTRAB9A
SCHEMBL16148623 0.75 HTT (0.55) SMN1; SMN2ALDH1A1LMNAKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014165816-A1 COMPOUNDS USEFUL FOR THE TREATMENT OF METABOLIC DISORDERS AND SYNTHESIS OF THE SAME NORTH CAROLINA CENTRAL UNIVERSITY (US) 2014-10-09 — — WO disclosed
Send feedback